United Therapeutics Corp. (UTHR)
497.11
-6.75
(-1.34%)
USD |
NASDAQ |
Sep 11, 16:00
497.01
-0.10
(-0.02%)
After-Hours: 20:00
United Therapeutics Price to Book Value : 3.315 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 3.315 |
| September 10, 2026 | 3.360 |
| September 09, 2026 | 3.379 |
| September 08, 2026 | 3.320 |
| September 04, 2026 | 3.251 |
| September 03, 2026 | 3.269 |
| September 02, 2026 | 3.281 |
| September 01, 2026 | 3.419 |
| August 31, 2026 | 3.403 |
| August 28, 2026 | 3.437 |
| August 27, 2026 | 3.520 |
| August 26, 2026 | 3.445 |
| August 25, 2026 | 3.458 |
| August 24, 2026 | 3.420 |
| August 21, 2026 | 3.422 |
| August 20, 2026 | 3.474 |
| August 19, 2026 | 3.528 |
| August 18, 2026 | 3.456 |
| August 17, 2026 | 3.390 |
| August 14, 2026 | 3.332 |
| August 13, 2026 | 3.342 |
| August 12, 2026 | 3.412 |
| August 11, 2026 | 3.437 |
| August 10, 2026 | 3.532 |
| August 07, 2026 | 3.593 |
| Date | Value |
|---|---|
| August 06, 2026 | 3.554 |
| August 05, 2026 | 3.461 |
| August 04, 2026 | 3.458 |
| August 03, 2026 | 3.443 |
| July 31, 2026 | 3.452 |
| July 30, 2026 | 3.506 |
| July 29, 2026 | 3.499 |
| July 28, 2026 | 3.492 |
| July 27, 2026 | 3.520 |
| July 24, 2026 | 3.524 |
| July 23, 2026 | 3.531 |
| July 22, 2026 | 3.514 |
| July 21, 2026 | 3.573 |
| July 20, 2026 | 3.530 |
| July 17, 2026 | 3.572 |
| July 16, 2026 | 3.528 |
| July 15, 2026 | 3.546 |
| July 14, 2026 | 3.512 |
| July 13, 2026 | 3.571 |
| July 10, 2026 | 3.648 |
| July 09, 2026 | 3.684 |
| July 08, 2026 | 3.696 |
| July 07, 2026 | 3.759 |
| July 06, 2026 | 3.649 |
| July 02, 2026 | 3.707 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Liquidia Corp. | 30.48 |
| MannKind Corp. | -- |
| Vertex Pharmaceuticals, Inc. | 6.449 |
| Alnylam Pharmaceuticals, Inc. | 24.56 |
| Savara, Inc. | 7.578 |
Price to Book Value Related Metrics
| PE Ratio | 17.78 |
| PS Ratio | 7.391 |
| PEG Ratio | 1.940 |
| Price to Free Cash Flow | 21.51 |
| Price | 497.11 |
| Earnings Yield | 5.62% |
| Market Cap | 21.22B |
| PEGY Ratio | 1.940 |
| Operating PE Ratio | 16.61 |
| Normalized PE Ratio | 19.05 |